Press release March 13, 2019
During 2018, Bio-Works has updated the quality management system according to the international standard ISO 9001: 2015. The system was fully introduced into the organization in January 2019. Bio-Works has now been audited and approved by an external certification organization, which means that the management system meets the requirements of the standard. The standard is harmonized with EU regulations and certification endorses the company’s ability to provide products that consistently meet both customer requirements and applicable legal requirements.
The certification covers product development, production, marketing and sales. By designing a quality management system with a strong customer focus where all processes and routines are carefully designed and quality tested according to international standards, Bio-Works ensures that it continues to deliver products and services in accordance with the requirements that the market demands. The certification is the result of systematic work that must constantly be carried out and prioritized in order to be able to offer products with high customer value.
Mats Johnson, Bio-Works CEO:
”The certification according to ISO 9001: 2015 is another important step in establishing Bio-Works as a reliable and long-term supplier for all our Life Science customers. Many of our customers must comply with various regulatory requirements and therefore require certified suppliers for their production. We know that several existing and potential customers have been waiting for our certification and we expect increased interest in our products. ”
For more information please visit Bio-Works’ homepage, www.bio-works,com, or contact Mats Johnson, CEO, e-mail: firstname.lastname@example.org, telephone: +46 70 516 53 37.
Bio-Works is a biotechnology company that develops, produces and sells innovative separation media products based on agarose to purify proteins, peptides and other biomolecules. The company’s products are mainly used for purifying biological drugs and diagnostic products, from the research phase to large-scale production. The products are sold globally partly through its own organization and partly through distributors. The Bio-Works facility is located in Uppsala Business Park in Uppsala, Sweden. The company’s share is listed on Nasdaq First North. FNCA Sweden AB, +46 (0) 8-528 00 399, email@example.com, is appointed Certified Adviser.